Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of MRE11A by UBQLN4 leads to cisplatin resistance in patients with esophageal squamous cell carcinoma
Tomohiro Murakami, Yoshiaki Shoji, Tomohiko Nishi, et al.
Molecular Oncology (2021) Vol. 15, Iss. 4, pp. 1069-1087
Open Access | Times Cited: 16

Showing 16 citing articles:

MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer
Matías A. Bustos, Takamichi Yokoe, Yoshiaki Shoji, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Melittin treatment prevents colorectal cancer from progressing in mice through ER stress-mediated apoptosis
Yan Luo, XU Chong-ming, Bo Luo, et al.
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 5, pp. 645-654
Closed Access | Times Cited: 11
Induced collagen type‐I secretion by hepatocytes of the melanoma liver metastasis is associated with a reduction in tumour‐infiltrating lymphocytes
Shodai Mizuno, Matías A. Bustos, Yoshinori Hayashi, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 3
Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer
Hugh Adam Nicholson, Lynne Sawers, Rosemary G. Clarke, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 7, pp. 1340-1351
Open Access | Times Cited: 15
Spatial profiling of cancer-associated fibroblasts of sporadic early onset colon cancer microenvironment
Satoru Furuhashi, Matías A. Bustos, Shodai Mizuno, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 7
UBQLN4 is activated by C/EBPβ and exerts oncogenic effects on colorectal cancer via the Wnt/β-catenin signaling pathway
Xiaolong Tang, Yahang Liang, Guorui Sun, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 14
UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer
Yoshiaki Shoji, Takamichi Yokoe, Yuta Kobayashi, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 9
Post-Translational Modification of MRE11: Its Implication in DDR and Diseases
Ruiqing Lu, Han Zhang, Yi-Nan Jiang, et al.
Genes (2021) Vol. 12, Iss. 8, pp. 1158-1158
Open Access | Times Cited: 12
GDF15 negatively regulates chemosensitivity via TGFBR2-AKT pathway-dependent metabolism in esophageal squamous cell carcinoma
Yingxi Du, Yarui Ma, Qing Zhu, et al.
Frontiers of Medicine (2022) Vol. 17, Iss. 1, pp. 119-131
Closed Access | Times Cited: 8
A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic Biomarker of Immune-Related Therapy in Pan-Cancer
Jie Li, Tong Ye, Zhi Wang, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-22
Open Access | Times Cited: 8
ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma
Yanlin Song, Yuan Cheng, Tianxia Lan, et al.
Cancer Letters (2022) Vol. 554, pp. 216012-216012
Open Access | Times Cited: 6
Ubiquilin-4 induces immune escape in gastric cancer by activating the notch signaling pathway
Quan Jiang, Xuejiao Chen, Shixin Zhou, et al.
Cellular Oncology (2023) Vol. 47, Iss. 1, pp. 303-319
Closed Access | Times Cited: 3
The Multiple Faces of the MRN Complex: Roles in Medulloblastoma and Beyond
Marialaura Petroni, Veronica La Monica, Francesca Fabretti, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3599-3599
Open Access | Times Cited: 2
TAPI-1 Exhibits Anti-tumor Efficacy in Human Esophageal Squamous Cell Carcinoma Cells via Suppression of NF-κB Signaling Pathway
Lin Gao, Li Li, Dongmei Zhang, et al.
Digestive Diseases and Sciences (2023)
Open Access | Times Cited: 2
The DMRTA1-SOX2 positive feedback loop promotes progression and chemotherapy resistance of esophageal squamous cell carcinoma
RUI ZHANG, Peng Zhou, XIA OU, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 6, pp. 887-897
Open Access | Times Cited: 1
Genomic Amplification of UBQLN4 Is a Prognostic and Treatment Resistance Factor
Yuta Kobayashi, Matías A. Bustos, Yoshiaki Shoji, et al.
Cells (2022) Vol. 11, Iss. 20, pp. 3311-3311
Open Access | Times Cited: 2
Page 1

Scroll to top